A meta-analysis by Tu et al. evaluated 904 patients across 11 studies who had undergone [68Ga]Ga-PSMA-11-PET/CT for untreated intermediate- or high-risk PCa prior to RP and pelvic lymphadenectomy. The gene discussed is FOLH1; the disease is posterior cortical atrophy.